AzTrials
AzTrials

Laryngeal CleftNCT07057258

Injection Versus Suture Repair of Laryngeal Clefts

A study testing Endoscopic suture repair and Injection laryngoplasty in people with Laryngeal Cleft and Dysphagia, run by Oregon Health and Science University at 2 sites in United States.

Enrolling by invitation

Enrolling by invitation. The study team selects and invites participants, usually from an existing group of patients.

Sites and contacts
Official record
Search all trials

Trial summary

The purpose of the study is to learn more about a procedure that may be helpful for the participant's swallowing issues. The investigators are hoping to find out if one type of procedure is the same or better than another type of procedure at improving participant's issues with swallowing. Read more about this study

Who is it for?
Ages 12 months to 10 years
Conditions the study is for
Laryngeal Cleft, Dysphagia
What is being tested?
Endoscopic suture repair and Injection laryngoplasty
Could I receive a placebo?
No, everyone receives an active treatment
How many people
128 participants
Where
2 sitesUnited States
Study dates
1 Sep 2025to 30 Dec 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 12 months to 10 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • children aged 12 months - 10 years referred to a multi-disciplinary aerodigestive clinic with evidence of penetration or aspiration on VFSS, requiring any amount of thickening of liquids and unable to wean after 2-month trial of thickened liquids.

Who cannot join

  • Cerebral palsy
  • Down syndrome
  • Prematurity < 28 weeks gestational age
  • Hypoxic brain injury
  • Any syndrome with significant hypotonia
  • History of nothing by mouth (NPO) for > 1 month prior to assessment
Show all 9Show fewer
  • >50% of nutrition by G-tube
  • Tracheostomy
  • History of prior IL or ER

Trial locations and contacts

2 sites in 1 country. Contact the study team or a site near you to ask about taking part.

United States2 sites
  • Vanderbilt University

    Nashville, Tennessee, 37232

  • Oregon Health & Science University

    Portland, Oregon, 97239

Other trials in United States

About this study

Official title: Injection Versus Suture Repair of Laryngeal Clefts, A Randomized, Controlled Trial

The purpose of the study is to learn more about a procedure that may be helpful for the participant's swallowing issues. The investigators are hoping to find out if one type of procedure is the same or better than another type of procedure at improving participant's issues with swallowing.

Participants will get one of two procedures. One is called injection laryngoplasty (IL) and injects a gel into the back wall of the participant's airway to prevent food and liquid from falling in. The other procedure is called endoscopic suture repair (ER) and uses sutures to sew together and build up the back wall of the participant's airway to prevent food and liquid from falling in. Participants will be asked to have a number of tests and procedures. These include a modified barium swallow study, in which the participant drinks and eats foods and liquids with barium in them and X-rays are used to assess how the food moves through the participant's body. This will be done before the procedure and 3 months after the procedure. The investigators will also give participants questionnaires to complete before and after the procedure.

Read the detailed description

This study has 2 study groups.

  • Group 1 will get IL for this condition.
  • Group 2 will get ER for this condition

A computer will assign each participant to a group in no particular order. This is called randomization. Half of participants in this study will get IL. Half of participants will get ER. Each participant will have an equal chance of being in either group.

Neither the participants, the study doctor(s), nor the speech pathologist will know whether each participant will get the IL or ER. Only the surgeon will know which treatment the participant gets. The study is done this way because knowing which method the participant receives can change the results of the study.

If participants experience any serious side effects, the study doctor can find out which method they received so that any side effects can be treated properly.

Participants will need to have the following tests to find out if they can be in the study:

  • Physical exam
  • Demographic information/medical history
  • Video fluoroscopic swallow study (VFSS) - X-ray videos that allow investigators to watch how food and liquids go down as a participant swallows them

If participant's screening tests show that they can take part in the study and they choose to be part of the study, they will also have to do the following tests:

  • VFSS 3 months after the procedure
  • Questionnaires asking about the emotional and physical burden of participant's swallowing issues, both before and after the procedure
  • Overnight monitoring in the hospital after the procedure
  • Follow up in clinic for up to 2 years after the procedure

Participant's medical records may be reviewed. Information reviewed may include treatment history, medications, surgeries, allergies, scans, and lab results.

Once participant's participation in the study ends, their medical provider(s) will help them choose the next step in their care.

Being tested
Endoscopic suture repair, Injection laryngoplasty
Keywords
endoscopic suture repair, injection laryngoplasty, pediatrics, otolaryngology, dysphagia, laryngeal cleft
Medical subject headings
Laryngeal cleft, Deglutition Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Endoscopic suture repairProcedure or surgery

    Children receiving endoscopic suture repair of laryngeal cleft

  • Injection laryngoplastyProcedure or surgery

    Children receiving injection of the interarytenoid space for laryngeal cleft treatment

Study groups in NCT07057258
Study groupRoleWhat they receive
Endoscopic suture repairExperimentalChildren receiving endoscopic suture repair of laryngeal cleft
Receives: Procedure: Endoscopic suture repair
Injection laryngoplastyActive comparatorChildren receiving injection of the interarytenoid space of laryngeal cleft
Receives: Procedure: Injection laryngoplasty

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Resolution of penetration/aspiration

    No thickener needed on speech pathologist assessment of video fluoroscopic swallow study

    Measured: 3 months post operative

Secondary outcomes (5)
  1. Compare change in recommended liquid thickness

    The recommend liquid thickness according to speech pathologist assessment of video fluoroscopic swallow study review will be converted to a numerical scale and compared to pre-intervention recommended thickness to determine the degree of change after the intervention. The liquid thickness will be measured based on the IDDSI (International Dysphagia Diet Standardisation Initiative) Framework in which recommended liquid is scored as thin (0), slightly thick (1), mildly thick (2), moderately thick (3), or extremely thick (4). Higher scores indicate need for thicker liquids and therefore higher degree of dysphagia.

    Measured: at enrollment and 3 months post intervention

  2. change in penetration/aspiration score

    The score according to the Penetration-Aspiration scale rating of the video fluoroscopic swallow study data will be compared before and after the intervention. The Penetration-Aspiration scale includes: material does not enter the airway (1), material enters the airway, remains above the vocal folds, and is ejected from the airway (2), material enters the airway, remains above the vocal folds, and is not ejected from the airway (3), material enters the airway, contacts the vocal folds, and is ejected from the airway (4), material enters the airway, contacts the vocal folds, and is not ejected from the airway (5), material enters the airway, passes below the vocal folds, and is ejected into the larynx or out of the airway (6), material enters the airway, passes below the vocal folds, and is not ejected from the trachea despite effort (7), material enters the airway, passes below the vocal folds, and no effort is made to eject (8). Higher scores indicate higher degree of dysphagia.

    Measured: at enrollment and 3 months post intervention

  3. change in feeding and swallowing impact survey (FSIS) scores

    Survey data including FSIS will be analyzed and change in score will be calculated before and after the intervention. The FSIS is a validated survey that includes 18 statements that caregivers rate on a scale of 1 to 5 in which lower scores indicate better quality of life.

    Measured: at enrollment and 3 months post intervention

  4. change in quality of life scores

    Survey data including the Child Health Questionnaire (CHQ) for children aged five years and older or the Infant Toddler Quality of Life Questionnaire (ITQOL) for children aged under five years will be analyzed and change in score will be calculated before and after the intervention. The CHQ consists of 28 questions that assess the global quality of life of the child. The ITQOL consists of 47 questions that assess the global quality of life of the child. Based on the responses, the questionnaires are converted to a scale that ranges from 0 (worst possible score) to 100 (best possible score).

    Measured: at enrollment and 3 months post intervention

  5. Change in laryngeal cleft quality of life (LC-QOL) scores

    Survey data including LC-QOL will be analyzed and change in score will be calculated before and after the intervention. The LC-QOL is a 40 item questionnaire designed to assess quality of life in caregivers of patients with laryngeal cleft. Each item is scored from 0 to 5 in which lower scores indicate more significant negative impact on quality of life due to caring for a child with laryngeal cleft.

    Measured: at enrollment and 3 months post intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Jul 2025
  2. Study start1 Sep 2025
  3. Primary completion1 Sep 2026 (estimated)
  4. Study completion30 Dec 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Randomized controlled trial
Masking
Triple blind
Who is masked
Participant, Care provider, Outcomes assessor
Enrolment
128 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07057258
Sponsor's protocol ID
STUDY00027965
Status last verified
Sep 2025
First submitted
2 Jun 2025
Last updated
29 Sep 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Endoscopic suture repair and Injection laryngoplasty in people with Laryngeal Cleft and Dysphagia, run by Oregon Health and Science University at 2 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: enrolling by invitation, as of the sponsor's last update on 29 Sep 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Resolution of penetration/aspiration (time frame: 3 months post operative). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Sep 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in